INDEMNIFICATION AGREEMENTIndemnification Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of , 20 by and between Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
SPRING BANK PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive PlanIncentive Stock Option Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
SPRING BANK PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2014 Stock Incentive PlanStock Option Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
SPRING BANK TECHNOLOGIES, INC. AND MICROLOGIX BIOTECH, INC. STOCK PURCHASE AGREEMENT DECEMBER 17, 2003Stock Purchase Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Stock Purchase Agreement (the “Agreement”) is made as of the 17th day of December 2003, by and between Spring Bank Technologies, Inc., a Massachusetts corporation having its principal office at 113 Cedar Street, Suite S-7, Milford, MA 01757, USA (the Company”) and Micrologix Biotech, Inc., a British Columbia corporation having its offices at BC Research Complex, 3650 Wesbrook Mall, Vancouver, BC, Canada V6S 2L2 (“Micrologix”).
Dr. Nezam Afdhal, M.D. Charlestown, MA 02129 Dear Nezam:Invention and Non-Disclosure Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
On behalf of Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter is to summarize the terms of your employment with the Company, should you accept our offer:
Jonathan P. Freve Northborough, MA 01532 Dear Jon:Spring Bank Pharmaceuticals, Inc. • January 5th, 2016 • Pharmaceutical preparations
On behalf of Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), I am pleased to set forth below the terms of your continued employment with the Company, which will take effect as of the date you counter-sign this letter agreement:
Radhakrishnan P. Iyer Shrewsbury, MA 01545 Dear Kris:Spring Bank Pharmaceuticals, Inc. • January 5th, 2016 • Pharmaceutical preparations
On behalf of Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), I am pleased to set forth below the terms of your continued employment with the Company, which will take effect as of the date you counter-sign this letter agreement:
TRANSITION AGREEMENTTransition Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Transition Agreement (the “Agreement”) is made by and between Spring Bank Pharmaceuticals, Inc. (the “Company”) and Douglas Jensen (“Mr. Jensen”) (collectively, the “Parties”) as of the 27th day of May 2015.
SPRING BANK PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
Consulting AgreementConsulting Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
SPRING BANK PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
LEASESpring Bank Pharmaceuticals, Inc. • January 5th, 2016 • Pharmaceutical preparations • Massachusetts
THE ROUTE 495 COMMERCE PARK LIMITED PARTNERSHIP, a limited partnership established under the laws of the Commonwealth of Massachusetts, BY JON BOVARNICK, AGENT FOR GENERAL PARTNER, DAVID BOVARNICK, having a usual place of business at 56 Kearney Road, Needham, Massachusetts 02494 (hereinafter “LESSOR”), which expression shall include its representatives, successors and assigns where the context so admits, does hereby lease to SPRING BANK PHARMACEUTICALS, INC., a Massachusetts business corporation with a place of business at 113 Cedar Street, Suite S-7. Milford, Massachusetts (hereinafter “LESSEE”), which expression shall include its successors, assigns, and representatives, and the LESSEE hereby leases the following premises described in Article II.
